aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
viernes, 31 de octubre de 2025
Morning Briefing: Today's News Summaries Friday, Oct 31 2025 9:09 AM ++++ ++++
Morning Briefing: Today's News Summaries
Friday, Oct 31 2025 9:09 AM
Many States — But Not All — Step Up To Help SNAP Beneficiaries Amid Deadline
https://kffhealthnews.org/morning-breakout/many-states-but-not-all-step-up-to-help-snap-beneficiaries-amid-deadline/
Kennedy Softens Warning On Tylenol; Study Ties Covid In Pregnancy, Autism
https://kffhealthnews.org/morning-breakout/kennedy-softens-warning-on-tylenol-study-ties-covid-in-pregnancy-autism/
HHS Drafts Plan To Effectively End Trans Care For Youths Nationwide
https://kffhealthnews.org/morning-breakout/hhs-drafts-plan-to-effectively-end-trans-care-for-youths-nationwide/
FDA's Block Of Mifepristone Access Is Unlawful, Federal Judge Rules
https://kffhealthnews.org/morning-breakout/fdas-block-of-mifepristone-access-is-unlawful-federal-judge-rules/
Insurers Blame Hospitals' Use Of AI, 'Aggressive' Coding For Price Spikes
https://kffhealthnews.org/morning-breakout/insurers-blame-hospitals-use-of-ai-aggressive-coding-for-price-spikes/
Telltale Signs Of Bird Flu Infection Aren't Always Evident, Review Finds
https://kffhealthnews.org/morning-breakout/telltale-signs-of-bird-flu-infection-arent-always-evident-review-finds/
Longer Looks: Interesting Reads You Might Have Missed
https://kffhealthnews.org/morning-breakout/longer-looks-interesting-reads-you-might-have-missed-239/
Viewpoints: Our Leaders Failed Us By Cutting Medicare Telehealth Coverage; Will Help For Chronic Pain Go Next?
https://kffhealthnews.org/morning-breakout/viewpoints-our-leaders-failed-us-by-cutting-medicare-telehealth-coverage-will-help-for-chronic-pain-go-next/
Biopharma’s agentic AI moment
Biopharma’s agentic AI moment
Owkin — an AI company focused on unraveling the complexity of biology and advancing new diagnostics and therapies — partnered with STAT Brand Studio on a Pulse Check report to survey more than 200 executives and researchers in the U.S. and Europe about agentic AI.
The report examines how leaders perceive this emerging technology, from its potential to streamline discovery and research to the strategic priorities, adoption strategies, budgets, and barriers that shape its role in biopharma.
https://www.statnews.com/biopharmas-agentic-ai-moment/
Health care takes center stage in this year’s elections, a sign of midterm strategies to come Democrats are tying health care to affordability issues, while Republicans try to leverage Trump’s recent announcements
https://www.statnews.com/2025/10/31/governors-races-health-care-politics-midterm-testing-grounds/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_icAdD2K-gk0-xh9nTz7UQGxeME9JULWy-x15a_CPAIVx8Ry2AVksy1mMrMgzSsHFHdPfq5NL8Qw1Cp3m4ZeI1xNy9AA&_hsmi=387732612&utm_content=387732612&utm_source=hs_email
Health care takes center stage for midterm elections
The results of next week’s governors’ races could have major implications on the parties’ midterm approaches to federal health policy.
In Virginia and New Jersey’s gubernatorial races, new lines of attack are opening up, with both Democrats and Republicans refining their central message to highlight their perceived strengths. Democrats want to link health issues with economic ones, seizing on voter frustrations around rising costs and cuts to health programs. Republicans, meanwhile, are touting Trump’s deals to lower drug prices.
If you’re a regular Morning Rounds reader, you don’t need me to tell you that American health care is undergoing a transformational shift, especially after the passage of Republicans’ One Big Beautiful Bill, which is set to slash Medicaid funding by nearly $1 trillion over the next decade. Elections are a great way to track how Americans are feeling about it all. Read more from STAT’s Daniel Payne.
Under Vinay Prasad, employees at a key FDA center fear speaking out, look for the exits Prasad is contending with slumping morale as senior leaders quit CBER By Lizzy LawrenceOct. 31, 2025
https://www.statnews.com/2025/10/31/vinay-prasad-fda-cber-management-issues-insiders-say/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_y8k5S3IjVh03QuCMdQhjP-h--yYZBPryAPOnZga3ALOHof4jClTFaa9o33_RTQFEAZWOtOQYMwqNWUQ4ZpZmHIExR7g&_hsmi=387732612&utm_content=387732612&utm_source=hs_email
Vinay Prasad’s tumultuous tenure at the Food and Drug Administration has entered a new, even rockier era: a slow-boiling feud with his staff that could lead to the exodus of dozens of scientists who regulate the nation’s vaccines, biological products, and blood supply.
Insiders say Prasad, as director and chief medical and scientific officer for the Center for Biologics Evaluation and Research, has cultivated a work environment rife with mistrust and paranoia since returning from his brief departure. They say Prasad has fired key leaders without explanation and struggled to communicate with staff. They also say his vision for the center, other than applying additional scrutiny to vaccines, is unclear.
Another fantastic story from STAT’s Lizzy Lawrence, who interviewed more than 15 current and former FDA staff, contractors, and regulatory experts about Prasad’s rocky tenure. Read on for why his second stint at the CBER has been even more chaotic than his first.
jueves, 30 de octubre de 2025
Alaska Supreme Court Rethinks Rules On Who Can Perform Abortions
Alaska Supreme Court Rethinks Rules On Who Can Perform Abortions
Last year, a superior court judge struck down a law that required abortions to be performed only by a doctor licensed by the state medical board, the Anchorage Daily News reported. Other states making news: Ohio, Maine, Florida, Missouri, and California.
https://kffhealthnews.org/morning-breakout/alaska-supreme-court-rethinks-rules-on-who-can-perform-abortions/
Study Links Health Issues Later In Life With Using Cannabis Before Age 15
Study Links Health Issues Later In Life With Using Cannabis Before Age 15
Researchers found ties between both physical and mental health issues with early cannabis use. Other health and wellness news is on Character.AI, anti-fall technology in assisted living, the benefits of flavanol-rich foods, and food allergy reminders ahead of Halloween.
https://kffhealthnews.org/morning-breakout/study-links-health-issues-later-in-life-with-using-cannabis-before-age-15/
Viral Infections Drastically Raise Risk Of Heart Disease And Stroke: Study
Viral Infections Drastically Raise Risk Of Heart Disease And Stroke: Study
Researchers have zeroed in on inflammation sparked by covid, flu, and shingles as one component that explains why some people face an elevated risk of cardiovascular disease after infection. Plus, a look at how air travel fuels disease spread.
https://kffhealthnews.org/morning-breakout/viral-infections-drastically-raise-risk-of-heart-disease-and-stroke-study/
Judge Quashes DOJ Effort To Acquire Private Patient Information
Judge Quashes DOJ Effort To Acquire Private Patient Information
Judge Jamal N. Whitehead of Federal District Court in the Western District of Washington ruled the Trump administration overstepped its authority when it sought data from a trans health provider. “When a federal agency issues a subpoena ... to intimidate and coerce providers into abandoning lawful medical care, it exceeds its legitimate authority and abuses the judicial process,” he said.
https://kffhealthnews.org/morning-breakout/judge-quashes-doj-effort-to-acquire-private-patient-information/
To Cut Drug Costs, FDA Paves Way For Easier Approval Of Copycat Biologics
To Cut Drug Costs, FDA Paves Way For Easier Approval Of Copycat Biologics
The draft framework announced Wednesday lowers the standards that companies need to meet to bring the drugs to market. Also, states try to lower drug prices by regulating PBMs; how the immigration crackdown is affecting elder care; and more.
https://kffhealthnews.org/morning-breakout/to-cut-drug-costs-fda-paves-way-for-easier-approval-of-copycat-biologics/
Healthcare.gov Unveils Updated Prices; Customers Could Pay Double Next Year
Healthcare.gov Unveils Updated Prices; Customers Could Pay Double Next Year
Newly posted prices on the federal marketplace show an average premium increase of 26%, but the actual increase will be closer to 114% unless Congress extends Obamacare tax credits, which are at the heart of the ongoing government shutdown. Meanwhile, military families say their refrigerators will be empty after food aid funding runs dry Saturday.
https://kffhealthnews.org/morning-breakout/healthcare-gov-unveils-updated-prices-customers-could-pay-double-next-year/
RFK, Jr.’s bungled science on thimerosal and vaccines Josh Bloom | October 28, 2025 ++++++´+
https://geneticliteracyproject.org/2025/10/28/rfk-jr-s-bungled-science-on-thimerosal-and-vaccines/?mc_cid=3c96341fc5&mc_eid=b73600b7ac
The fake Tylenol-causes-autism scare has revived an ancient debate: When should you treat a fever?
https://geneticliteracyproject.org/2025/10/28/the-fake-tylenol-causes-autism-scare-has-revived-an-ancient-debate-when-should-you-treat-a-fever/?mc_cid=3c96341fc5&mc_eid=b73600b7ac
‘She started having orgasms for the first time in years’: More and more women are embracing testosterone’s sex and energy jolt
https://geneticliteracyproject.org/2025/10/28/she-started-having-orgasms-for-the-first-time-in-years-more-and-more-women-are-embracing-testosterones-sex-and-energy-jolt/?mc_cid=3c96341fc5&mc_eid=b73600b7ac
Vaccines, raw milk, fluoride, Tylenol: MAHA right-wing alliance floods state houses with hundreds of science-rejectionist bills
https://geneticliteracyproject.org/2025/10/28/vaccines-raw-milk-fluoride-tylenol-maha-right-wing-alliance-floods-state-houses-with-hundreds-of-science-rejectionist-bills/?mc_cid=3c96341fc5&mc_eid=b73600b7ac
Republican states win case striking down rule protecting transgender health care rights
https://geneticliteracyproject.org/2025/10/27/republican-states-win-case-striking-down-rule-protecting-transgender-health-care-rights/?mc_cid=3c96341fc5&mc_eid=b73600b7ac
Should we use CRISPR gene editing to remake humanity?
https://geneticliteracyproject.org/2025/10/27/should-we-use-crispr-gene-editing-to-remake-humanity/?mc_cid=3c96341fc5&mc_eid=b73600b7ac
A new therapy has been developed that promoters claim can remove microplastics from the body. Is it safe? Does it work?
A new therapy has been developed that promoters claim can remove microplastics from the body. Is it safe? Does it work?
Daniel Gilbert, Shannon Osaka | Washington Post | October 27, 2025
https://geneticliteracyproject.org/2025/10/27/a-new-therapy-has-been-developed-that-promoters-claim-can-remove-microplastics-from-the-body-is-it-safe-does-it-work/?mc_cid=3c96341fc5&mc_eid=b73600b7ac
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies Draft Guidance for Industry October 2025
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/scientific-considerations-demonstrating-biosimilarity-reference-product-updated-recommendations?utm_medium=email&utm_source=govdelivery
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
https://www.fda.gov/news-events/press-announcements/fda-moves-accelerate-biosimilar-development-and-lower-drug-costs?utm_medium=email&utm_source=govdelivery
FDA Issues Draft Guidance to Industry, “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies”
Today, FDA released a draft guidance for industry “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies.” This draft guidance describes updated scientific considerations regarding a comparative clinical study with efficacy endpoints (comparative efficacy study or CES) intended to support a demonstration of biosimilarity.
Since publication of the Scientific Considerations Guidance in April 2015, FDA has gained significant experience in evaluating analytical differences between proposed biosimilar products and reference products and understanding their impact on clinical performance. As experience with the development and approval of biosimilars has grown, there has been increasing recognition that CES are not as sensitive as modern analytical technologies for detecting differences between products. Accordingly, FDA’s scientific approach to when a CES may be needed to support a demonstration of biosimilarity is evolving. The draft guidance provides an overview of important scientific considerations for determining when a CES may inform a demonstration of biosimilarity.
FDA is issuing this draft guidance to seek public comment through the accompanying docket (Docket No. FDA-2011-D-0605). Visit Regulations.gov for instructions on how to comment.
This draft guidance describes scientific considerations that support a streamlined approach to demonstrating biosimilarity, which should reduce the time and cost of biosimilar development and help increase access to medications for American patients.
The 2025 report of the Lancet Countdown on health and climate change +...
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01919-1/abstract
The 2025 report of the Lancet Countdown on health and climate change provides the most comprehensive assessment to date of the connections between climate change and health, including new metrics which record deaths from extreme heat and wildfire smoke, the coverage of urban blue spaces (rivers, lakes, and coastlines), health adaptation funding, and individual engagement with health and climate change.
Our global food system is increasingly under strain. What needs to be done? Ian Proudfoot, Isabelle Allen | World Economic Forum | October 30, 2025 +++++
https://geneticliteracyproject.org/2025/10/30/our-global-food-system-is-increasingly-under-strain-what-needs-to-be-done/
How will climate change affect the flowers of the future?
Annelie Berner | MIT Technology Review | October 30, 2025
https://geneticliteracyproject.org/2025/10/30/how-will-climate-change-affect-the-flowers-of-the-future/
The social roots of sustainable eating
Emily Halnon | University of Georgia | October 30, 2025
https://geneticliteracyproject.org/2025/10/30/the-social-roots-of-sustainable-eating/
How AI can improve food safety and nutrition
Sedat Arslan | Academia | October 29, 2025
https://geneticliteracyproject.org/2025/10/29/how-ai-can-improve-food-safety-and-nutrition/
As China doubles down rejecting U.S. exports of soybeans, food security takes central focus in next 5-year agricultural plan
South China Morning Post | October 29, 2025
https://geneticliteracyproject.org/2025/10/29/as-china-doubles-down-rejecting-u-s-exports-of-soybeans-food-security-takes-central-focus-in-next-5-year-agricultural-plan/
‘‘It could determine the future of the world’: Putin morphs from ethical opponent of gene editing humans to support for creating CRISPR-edited soldiers “without fear, without compassion, without regret or even pain.” It could happen soon Stepan Kravchenko | Bloomberg | October 30, 2025
https://geneticliteracyproject.org/2025/10/30/it-could-determine-the-future-of-the-world-putin-morphs-from-ethical-opponent-of-gene-editing-humans-to-support-for-creating-crispr-edited-soldiers-without-fear-w/
Resurrecting Neanderthals: The scientific challenge and ethical debate
Kristina Killgrove | Live Science | October 30, 2025
https://geneticliteracyproject.org/2025/10/30/resurrecting-neanderthals-the-scientific-challenge-and-ethical-debate/
November 6, 2025: Digital Health Advisory Committee Meeting Announcement November 6, 2025
https://www.fda.gov/advisory-committees/advisory-committee-calendar/november-6-2025-digital-health-advisory-committee-meeting-announcement-11062025?utm_medium=email&utm_source=govdelivery
Meeting Materials and Due Date Reminders: Digital Health Advisory Committee Meeting
On November 6, 2025, the Digital Health Advisory Committee will discuss and make recommendations on the topic of generative artificial intelligence-enabled digital mental health medical devices. The Committee will discuss the benefits, risks to health, and risk mitigations that might be considered for these new digital mental health devices, including premarket evidence and post-market monitoring considerations. The meeting is open to the public. Registration is not required to attend.
The FDA has now made available the following meeting materials:
Agenda for the November 6, 2025 Digital Health Advisory Committee Meeting
https://www.fda.gov/media/189389/download?attachment=&utm_medium=email&utm_source=govdelivery
Roster for the November 6, 2025 Digital Health Advisory Committee Meeting
https://www.fda.gov/media/189390/download?attachment=&utm_medium=email&utm_source=govdelivery
Executive Summary for the November 6, 2025 Digital Health Advisory Committee Meeting
https://www.fda.gov/media/189391/download?attachment=&utm_medium=email&utm_source=govdelivery
FDA Discussion Questions for the November 6, 2025 Digital Health Advisory Committee Meeting
https://www.fda.gov/media/189392/download?attachment=&utm_medium=email&utm_source=govdelivery
Meeting date and time:
November 6, 2025, from 9:00 a.m. to 6:00 p.m. Eastern Time
Location:
The advisory committee meeting will be held virtually. The meeting will be heard, viewed, captioned, and recorded for through an online teleconferencing and/or video conferencing platform.
miércoles, 29 de octubre de 2025
Medicare Beneficiaries Are Not Luddites Author: Drew Altman Published: Oct 29, 2025
https://www.kff.org/from-drew-altman/medicare-beneficiaries-are-not-luddites/
In a new column, President and CEO Dr. Drew Altman discusses new KFF survey data that shows that a surprising share of older adults with Medicare are using health tech regularly, and a solid majority support many of CMS’ goals to make it more widely available. But there are also big income gaps in the use of health tech, and concerns about AI, privacy, and other barriers to rapid and more widespread adoption. “Apparently… a lot of Medicare beneficiaries—but not all beneficiaries equally—are ready for more health tech, and have become tech savvy to survive,” Altman writes.
Germany To Put $1B Toward Holocaust Survivors’ Home Care In 2026
Germany To Put $1B Toward Holocaust Survivors’ Home Care In 2026
Data show that survivors are dealing with more complicated health needs and increased disability as the average age of survivors rises. Other news from around the globe is on Chinese scientists, "fertility tourism," heat deaths, and more.
https://kffhealthnews.org/morning-breakout/germany-to-put-1b-toward-holocaust-survivors-home-care-in-2026/
Prison Phone Rates Going Up; Critics Predict ‘Huge Implications’ On Health
Prison Phone Rates Going Up; Critics Predict ‘Huge Implications’ On Health
The FCC voted Tuesday to dramatically raise the price limits that jails and prisons can charge. The calls, which are usually paid for by family members and friends outside of prison, have been shown to provide many mental and public health benefits, such as promoting relationships with children and reducing recidivism.
https://kffhealthnews.org/morning-breakout/prison-phone-rates-going-up-critics-predict-huge-implications-on-health/
Health Experts Warn Medicare Staffing Shortage Will Impact Open Enrollment
Health Experts Warn Medicare Staffing Shortage Will Impact Open Enrollment
CMS has been urged to boost staffing in order to ensure that benefits get delivered and communicated well during Medicare's open enrollment period. Other news is on the appointment of the director of Medicaid and CHIP, Bausch Health's exit from the 340B program, and more.
https://kffhealthnews.org/morning-breakout/health-experts-warn-medicare-staffing-shortage-will-impact-open-enrollment/
HHS Fires Top Official, A Vaccine Critic Who Says Coup To Oust RFK Jr. Is Afoot
HHS Fires Top Official, A Vaccine Critic Who Says Coup To Oust RFK Jr. Is Afoot
Senior adviser Steven J. Hatfill was accused of misrepresenting his role and “not coordinating policy-making with leadership.” When he declined a request to resign, chief of staff Matt Buckham fired him. Plus, a lower-dose covid shot is available for seniors and others at risk for severe infection.
https://kffhealthnews.org/morning-breakout/hhs-fires-top-official-a-vaccine-critic-who-says-coup-to-oust-rfk-jr-is-afoot/
Trump Admin Clawing Back Authority Over States’ Medical Debt Protections
The Consumer Financial Protection Bureau contends federal law invalidates state laws that prevent patients' medical debts from being reported to credit bureaus. Separately, male veterans who have breast cancer will find it harder to get health care coverage. Plus, Texas sues the maker of Tylenol.
https://kffhealthnews.org/morning-breakout/trump-admin-clawing-back-authority-over-states-medical-debt-protections/
Judge Bans White House From Firing Federal Workers During Shutdown
https://kffhealthnews.org/morning-breakout/judge-bans-white-house-from-firing-federal-workers-during-shutdown/
On Tuesday, U.S. District Judge Susan Illston of San Francisco blocked the firings, stating that the labor unions would likely win their claims that the cuts were arbitrary and politically motivated.
martes, 28 de octubre de 2025
Texas Doctor Gives Up License After Being Sued For Providing Gender Care +++
https://kffhealthnews.org/morning-breakout/texas-doctor-gives-up-license-after-being-sued-for-providing-gender-care/
Pediatrician May Lau has decided to move her practice from Dallas to Oregon after being sued last year by Texas Attorney General Ken Paxton and accused of prescribing testosterone to at least 21 patients, which she denies. More news is from Virginia, California, New Mexico, Maryland, Arizona, South Carolina, Massachusetts, Utah, and Florida.
BJC Health Failed To Alert School District About Shooter, Lawsuit Claims
The family of Jean Kuczka, a teacher slain in the 2022 shooting at CVPA in St. Louis, has filed a wrongful death suit against BJC Health, alleging that it failed to make the school aware of the threat after the shooter told multiple BJC mental health providers that he planned to “shoot up my old high school” in the two months before the attack.
https://kffhealthnews.org/morning-breakout/bjc-health-failed-to-alert-school-district-about-shooter-lawsuit-claims/
Young People In Corn Belt Are Getting Significantly More Cancer Since 2015
An analysis by The Washington Post found that in the past decade, cancer rates in the six states with the highest corn production are rising more rapidly than in the country as a whole. People aged 15-49 living there have shown a 5% increase in overall cancer rates, with kidney and skin cancer soaring to 35%-65% higher than the national average.
https://kffhealthnews.org/morning-breakout/young-people-in-corn-belt-are-getting-significantly-more-cancer-since-2015/
Obamacare Premiums Will Climb 30% On Average Next Year +++
https://kffhealthnews.org/morning-breakout/obamacare-premiums-will-climb-30-on-average-next-year/
The news of premium spikes arrives during the prolonged federal government shutdown, which was prompted in part by a fight over the extension of Obamacare subsidies. Higher premiums and a loss of subsidies could mean skyrocketing health care costs for millions. More coverage is on SNAP, WIC, and other impacts of the shutdown.
NIH Installation Of Vance Pal To Lead Environmental Health Sciences Panned
https://kffhealthnews.org/morning-breakout/nih-installation-of-vance-pal-to-lead-environmental-health-sciences-panned/
Some fear the elevation of Kyle Walsh to a director's role — a promotion that didn't abide by standard procedures — will pave the way for future political appointments. Plus, President Trump issues an all-caps missive about Tylenol, touts his "perfect" MRI findings, and more.
California Ponies Up $140 Million To Preserve Planned Parenthood Clinics
The Golden State is tapping local funds to ensure the organization can maintain reproductive health services after the federal government cut funding. Plus, as Wyoming moves to prevent regulation of crisis pregnancy centers that counsel against abortion, some centers across the states expand medical services.
https://kffhealthnews.org/morning-breakout/california-ponies-up-140-million-to-preserve-planned-parenthood-clinics/
Medicare Advantage Enrollees Have Access to About Half of the Physicians Available to Traditional Medicare Beneficiaries Authors: Matthew Rae, Jeannie Fuglesten Biniek, Tricia Neuman, and Karen Pollitz Published: Oct 27, 2025
https://www.kff.org/medicare/medicare-advantage-enrollees-have-access-to-about-half-of-the-physicians-available-to-traditional-medicare-beneficiaries/
Medicare Advantage enrollees were in a plan that included just under half (48%) of all physicians available to traditional Medicare beneficiaries in their area in 2022, on average. The limitations of provider networks illustrate one of the key tradeoffs for beneficiaries in choosing Medicare Advantage for their coverage.
Will Trump’s Announcement Expand Access to IVF? Authors: Alina Salganicoff, Brittni Frederiksen, and Usha Ranji Published: Oct 27, 2025
https://www.kff.org/womens-health-policy/will-trumps-announcement-expand-access-to-ivf/
The White House announcement focused on reducing the cost of some IVF drugs and clarifying options for employers to offer standalone fertility benefits for their employees and their dependents. This policy watch examines some key takeaways about the Trump IVF plan.
8 Things to Watch for the 2026 ACA Open Enrollment Period Authors: Rayna Wallace, Jared Ortaliza, Matt McGough, Cynthia Cox, Emma Wager, Michelle Long, and Kaye Pestaina Published: Oct 28, 2025
https://www.kff.org/affordable-care-act/8-things-to-watch-for-the-2026-aca-open-enrollment-period/
The ACA Marketplace Open Enrollment season begins November 1, and with it comes looming changes to the enhanced premium tax credits, increases in out-of-pocket premiums, and changes to Marketplace enrollment and eligibility rules. Here are eight things to know about the 2026 Open Enrollment period.
GLP-1 Drugs Have Rapidly Lowered American Obesity Rates, Survey Shows
https://kffhealthnews.org/morning-breakout/glp-1-drugs-have-rapidly-lowered-american-obesity-rates-survey-shows/
According to the Gallup National Health and Well-Being Index, the U.S. obesity rate fell from 39.9% in 2022 to 37% in 2025. Plus: Women may need less exercise than men to improve heart health.
Stillbirths In US Occur Far More Often Than Previously Reported, Study Finds
https://kffhealthnews.org/morning-breakout/stillbirths-in-us-occur-far-more-often-than-previously-reported-study-finds/
Researchers found that between 2016 and 2022, there was one stillbirth for every 147 births, The Washington Post reported. Worse yet, a significant number of them happened without warning in pregnancies that did not show any previously identified risks.
Cigna Will Scrub Drug Rebate Models From Some Plans Starting In 2027
https://kffhealthnews.org/morning-breakout/cigna-will-scrub-drug-rebate-models-from-some-plans-starting-in-2027/
As Bloomberg explains, pharmaceutical companies pay the rebates in order to get favorable placement on pharmacy benefit managers’ lists of covered drugs, a practice some have likened to kickbacks. All of Cigna's Evernorth customers will have access to upfront discounts starting in 2028.
Mental Health Grants For Schools Must Be Restored, Judge Rules
https://kffhealthnews.org/morning-breakout/mental-health-grants-for-schools-must-be-restored-judge-rules/
The Trump administration had canceled the grants, claiming they were not awarded based on merit. The judge said the states made a case for real harm from the cuts to the grants meant to help with a shortage of mental health workers in schools. Also, more than 1 million people show suicidal intent each week while talking to chatbots.
As States Prep To Sue Over Food Aid, Some In GOP Seek Separate SNAP Vote
https://kffhealthnews.org/morning-breakout/as-states-prep-to-sue-over-food-aid-some-in-gop-seek-separate-snap-vote/
Democrat-led states are petitioning for the government to tap an emergency fund to keep food aid flowing amid the shutdown — after the Trump administration said it would not do that. Meanwhile, a Texas grocer has a plan to help families in need; Connecticut issues emergency relief; and more.
In Pivot, Federal Workers’ Union Calls For Immediate End To Shutdown
https://kffhealthnews.org/morning-breakout/in-pivot-federal-workers-union-calls-for-immediate-end-to-shutdown/
The president of the American Federation of Government Employees suggested that negotiations over Democrats' health care demands should continue only after the government is reopened. Separately, news outlets cover the Obamacare price hikes headed for residents in New Jersey, Illinois, Arizona, and Colorado.
lunes, 27 de octubre de 2025
domingo, 26 de octubre de 2025
It’s a Bird! It’s a Plane! It’s a Chemtrail? New Conspiracy Theory Takes Wing at Kennedy’s HHS By Stephanie Armour October 16, 2025
https://kffhealthnews.org/news/article/chemtrails-conspiracy-fringe-theory-maha-kennedy-hhs/
The ideas that airplane vapors are toxic to people and that there are ongoing efforts to intentionally change the climate have long made the social media rounds. Now, they have found advocates at the Department of Health and Human Services.
HHS Secretary Robert F. Kennedy Jr. is planning to investigate climate and weather control and is expected to create a task force that will recommend possible federal action, according to a former agency official, an internal agency memo obtained by KFF Health News, and a consultant who helped with the memo.
Under President Donald Trump, unscientific ideas have unusual power to take hold and shape public health policy.
U.S. Foreign Aid Freeze & Dissolution of USAID: Timeline of Events Oct 24, 2025 +... (x)
https://www.kff.org/
This timeline provides a detailed overview of actions, including counter-actions, related to the administration’s efforts to freeze all U.S. foreign aid and dissolve the U.S. Agency for International Development (USAID).
sábado, 25 de octubre de 2025
KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version Irving Washington , Hagere Yilma , and Joel Luther
https://www.kff.org/health-information-trust/parents-trust-in-childrens-health-content-on-social-media-and-unfounded-claims-about-abortion-pill-safety/?utm_campaign=22234741-KFF-Information-Trust&utm_medium=email&_hsenc=p2ANqtz-_aM8eOKVFztadDG79Flc51yrCV7yLvQji-5vaeig-b0ourSDFwC3GRwly2mj-TvPly8WLXjKNs1e22IAWUnztyx5uf6w&_hsmi=386549812&utm_content=386549812&utm_source=hs_email
This volume highlights the latest release from the KFF/The Washington Post Survey of Parents, which finds that most parents report seeing children’s health content on social media, but many are unsure how to evaluate the trustworthiness of advice shared by health and wellness influencers. It also reviews misleading claims about the safety of medication abortion following the approval of a generic version of the abortion pill mifepristone, and it explores reports that federal officials are considering adding autism to the list of conditions covered by the Vaccine Injury Compensation Program. Lastly, it examines the use of AI chatbots by patients seeking to interpret lab results.
viernes, 24 de octubre de 2025
ACA Premium Payments Would More than Double on Average If Enhanced Tax Credits Expire
ACA Premium Payments Would More than Double on Average If Enhanced Tax Credits Expire
How much more could people who buy their insurance from the ACA Marketplaces pay if the enhanced premium tax credits expire at the end of the year? KFF’s Cynthia Cox walks through three real-life examples of how the expiration of the enhanced premium tax credits would affect a family of four, a young working person, and a couple near retirement age.
https://www.youtube.com/shorts/Czn5QuvmISo
The Semi-Sad Prospects for Controlling Employer Health Care Costs Author: Drew Altman Published: Oct 22, 2025
https://www.kff.org/from-drew-altman/the-semi-sad-prospects-for-controlling-employer-health-care-costs/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_DqLVD2eZfG88YtHKW7rIAwq04m7Cl6d0Qci9zUp6KvE8TIB3es_uCkpCK7wpqq1OUgyZ8hyy_pTZ5R_0wYCyU9qGDPw&_hsmi=386723832&utm_content=386723832&utm_source=hs_email
In a commentary on KFF's 27th Employer Health Benefits Survey, President and CEO Dr. Drew Altman discusses the obstacles employers face trying to control their health care costs, and the reasons why they’ve never been meaningful supporters of government cost-containment efforts. He predicts that premium increases expected next year could lead to a new wave of higher deductibles and other forms of cost sharing for the 155 million Americans who rely on employer coverage.
Furloughed CMS Employees To Return Temporarily For Open Enrollment
https://kffhealthnews.org/morning-breakout/furloughed-cms-employees-to-return-temporarily-for-open-enrollment/
Employees have been furloughed since the government shut down three weeks ago. Meanwhile, federal workers have begun missing paychecks, and Democrats blocked a bill that would have allowed some workers to be paid.
Federal Judge Overturns Protections For Transgender Health Care
https://kffhealthnews.org/morning-breakout/federal-judge-overturns-protections-for-transgender-health-care/
The Biden-era rule, which barred discrimination against sexual orientation and gender identity in certain health programs and activities, was struck down Wednesday by Judge Louis Guirola Jr. of the U.S. District Court for the Southern District of Mississippi.
Howard University Hospital In D.C. Could Be Teetering On Edge Of Closure
https://kffhealthnews.org/morning-breakout/howard-university-hospital-in-d-c-could-be-teetering-on-edge-of-closure
The hospital is a lifeline for patients who are heavily reliant on Medicare and Medicaid, The Wall Street Journal reported. But after major cuts in federal funding, “This is a very vulnerable hospital,” said Dr. Andrea Hayes Dixon, senior VP of health affairs at Howard University College of Medicine.
Launch Prices For Some Medications Outpace Inflation, Review Finds
https://kffhealthnews.org/morning-breakout/launch-prices-for-some-medications-outpace-inflation-review-finds/
The cost when new drugs hit the market are up 51% after discounts, Stat reports. Other pharmaceuticals in the news include generic Trikafta, Enbrel, Blenrep, and more.
NYC Wipes Out $135M In Medical Debt, Easing Burden For 75,000 Residents
https://kffhealthnews.org/morning-breakout/nyc-wipes-out-135m-in-medical-debt-easing-burden-for-75000-residents/
Residents who qualify for this one-time debt relief program will be notified by Undue Medical Debt. Separately, Maryland Gov. Wes Moore decries FEMA's decision to withhold disaster aid.
A Miracle’: Girl, 12, Who Was Gravely Hurt In Minn. Shooting Leaves Hospital
https://kffhealthnews.org/morning-breakout/a-miracle-girl-12-who-was-gravely-hurt-in-minn-shooting-leaves-hospital/
Sophia Forchas, who was shot in the head, was the most seriously wounded child among those who survived the Aug. 27 attack at the Church of the Annunciation in Minneapolis, AP reported. Surgeons removed the left half of her skull. On Thursday, she was greeted with cheers after being taken around town in a limousine.
Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments October 2025
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-focused-drug-development-selecting-developing-or-modifying-fit-purpose-clinical-outcome?utm_medium=email&utm_source=govdelivery
FDA Issues Final Guidance on Patient-Focused Drug Development
The U.S. Food and Drug Administration issued a final guidance “Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments; Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders.” This guidance (Guidance 3) is the third in a series of guidance documents intended to facilitate the advancement and use of systematic approaches to collect and use robust and meaningful patient and caregiver input that can more consistently inform medical product development and regulatory decision-making.
The purpose of this guidance is to help sponsors identify or develop fit-for-purpose Clinical Outcome Assessment measures of patients’ health that are appropriate for use in a medical product development program.
jueves, 23 de octubre de 2025
Explaining Individual Coverage Health Reimbursement Arrangements (ICHRAs) Published: Oct 22, 2025
https://www.kff.org/private-insurance/explaining-individual-coverage-health-reimbursement-arrangements-ichras/
This policy explainer describes what Individual Coverage Health Reimbursement Arrangements (ICHRAs) are and how do they differ from typical employer-sponsored health care plans.
The Semi-Sad Prospects for Controlling Employer Health Care Costs Author: Drew Altman Published: Oct 22, 2025
https://www.kff.org/from-drew-altman/the-semi-sad-prospects-for-controlling-employer-health-care-costs/
In a commentary on KFF’s 27th employer health benefits survey, President and CEO Dr. Drew Altman discusses the obstacles employers face trying to control their health care costs, and the reasons why they’ve never been meaningful supporters of government cost-containment efforts. He predicts that premium increases expected next year could lead to a new wave of higher deductibles and other forms of cost sharing for the 155 million Americans who rely on employer coverage. Read the column here.
Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss Published: Oct 22, 2025
https://www.kff.org/health-costs/perspectives-from-employers-on-the-costs-and-issues-associated-with-covering-glp-1-agonists-for-weight-loss/
While more large employers are covering GLP-1 drugs for weight loss, KFF's conversations with employers highlight concerns about the cost of these medications. Many of these employers have considered scaling back coverage of GLP-1 agonists for weight loss, or in some cases, employers are adding or strengthening coverage requirements.
KFF/The Washington Post Survey of Parents: Exposure to and Trust in Children’s Health-Related Information Online
These findings from a KFF/Washington Post survey reveal how parents encounter information related to children's health on social media, including trust in content they see online and whether they have specific, trusted influencers when it comes to information about children's health.
https://www.kff.org/public-opinion/kff-the-washington-post-survey-of-parents-exposure-to-and-trust-in-childrens-health-related-information-online/
KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version Irving Washington , Hagere Yilma , and Joel Luther
https://www.kff.org/health-information-trust/parents-trust-in-childrens-health-content-on-social-media-and-unfounded-claims-about-abortion-pill-safety/
This volume shares findings from the KFF/The Washington Post Survey of Parents about exposure to and trust in children’s health content on social media, along with misleading claims following the approval of a generic version of mifepristone, reports of autism possibly being added to the Vaccine Injury Compensation Program, and patients using AI chatbots to interpret lab results.
Study: Gum Disease Might Be Linked To Poor Heart And Brain Health
https://kffhealthnews.org/morning-breakout/study-gum-disease-might-be-linked-to-poor-heart-and-brain-health/
In two studies released Wednesday, both published in Neurology Open Access, researchers found associations between gum disease and damage to the brain's white matter, as well as inflammation that can lead to atherosclerosis. Add cavities to the mix, and the risk of stroke increases by 86%.
WVa Medical Cannabis Program Has Raked In $34 Million But Has Spent $0
https://kffhealthnews.org/morning-breakout/wva-medical-cannabis-program-has-raked-in-34-million-but-has-spent-0/
West Virginia officials say the money will remain unspent until federal law, which classifies cannabis as an illegal drug, changes. Other news from around the nation comes out of North Carolina, Maryland, and California. Also: the fight to influence paid family leave policy.
FDA Redacts Names Of Drugs From Reports On Contaminated Factories
https://kffhealthnews.org/morning-breakout/fda-redacts-names-of-drugs-from-reports-on-contaminated-factories/
ProPublica reports that, according to the FDA, releasing the names of the drugs in inspection reports on foreign facilities would violate federal law protecting confidential commercial information. Experts worry that removing this data renders the reports useless for keeping Americans safe.
Bird Flu Infections Surging In Poultry And Cattle; Measles Outbreaks Swelling
https://kffhealthnews.org/morning-breakout/bird-flu-infections-surging-in-poultry-and-cattle-measles-outbreaks-swelling/
With no clear picture of the scope of the U.S. bird flu surge — federal agencies have stopped communicating during the shutdown — state health officials are left to fend for themselves to cope with outbreaks. Meanwhile, Utah, Arizona, and South Carolina are measles hot spots.
OB-GYN Group Urges Members To Support Contraception, Fight Misinfo
https://kffhealthnews.org/morning-breakout/ob-gyn-group-urges-members-to-support-contraception-fight-misinfo/
An official at the American College of Obstetricians and Gynecologists has stressed the importance of helping "patients get access to the evidence-based care they need and deserve." Also: Nurses are going on strike at Tenet Health hospitals in California; a look at the maternity care deserts in Minnesota; and more.
Deportees Recount Horrors Of Hours Spent In ICE’s Full-Body Restraints
https://kffhealthnews.org/morning-breakout/deportees-recount-horrors-of-hours-spent-in-ices-full-body-restraints/
The use of the WRAP — also called “the burrito” or “the bag” — has been criticized as inhumane by deportees and their advocates. Federal lawsuits liken incorrect usage of the device to punishment and even torture, AP reports. Plus, pregnant people decry the care they receive at detention facilities.
Trump Might Replace ACA, Oz Says; 25 States Will Halt SNAP Amid Shutdown
https://kffhealthnews.org/morning-breakout/trump-might-replace-aca-oz-says-25-states-will-halt-snap-amid-shutdown/
CMS Administrator Mehmet Oz told NBC News’ “Meet the Press” on Wednesday that President Donald Trump "has a plan" to redo Obamacare, which is at the heart of the federal shutdown. Oz didn't offer specifics but said, "There’s all kinds of ideas.” Meanwhile, dozens of states say they don't have enough funding to run the Supplemental Nutrition Assistance Program after Nov. 1.
miércoles, 22 de octubre de 2025
Gilead To Keep States’ HIV Drug Prices Steady After Earlier Saying They’d Rise +++
https://kffhealthnews.org/morning-breakout/gilead-to-keep-states-hiv-drug-prices-steady-after-earlier-saying-theyd-rise/
The agreement provides relief to federally funded programs that provide free or low-cost drugs to around 110,000 low-income people nationwide. Other news is on the side effects of antidepressants; the cause of auditory hallucinations in schizophrenia; ivermectin as a cancer treatment; and more.
Private Equity Firms Blackstone, TPG To Buy Hologic For $13 Billion
https://kffhealthnews.org/morning-breakout/private-equity-firms-blackstone-tpg-to-buy-hologic-for-13-billion/
Hologic — which makes mammography systems, breast imaging technology, and biopsy equipment — will go private in the deal. Other health industry news is on home infusion, death rates at U.S. dialysis centers, the shuttering of obstetric services at an Ohio hospital, and more.
Hundreds Of Disability Advocates Urge NC Legislature To Repeal Medicaid Cuts
https://kffhealthnews.org/morning-breakout/hundreds-of-disability-advocates-urge-nc-legislature-to-repeal-medicaid-cuts/
The state's Department of Health and Human Services slashed reimbursement for Medicaid-covered services on Oct. 1, North Carolina Health News reported. Other health news is from Mississippi, Minnesota, New Jersey, California, and Montana. Plus: A nationwide shrimp recall widens.
Amid Shutdown, Health Care Lobbyists Tiptoe Around Topics To Pursue Wins
https://kffhealthnews.org/morning-breakout/amid-shutdown-health-care-lobbyists-tiptoe-around-topics-to-pursue-wins/
Health care advocates tread a delicate line when it comes to discussions about politically charged ACA subsidies, but they see opportunities to sway lawmakers on bipartisan issues such as telehealth. Meanwhile, moderate Republicans lean on House leadership to address expiring ACA subsidies.
ICE Detainees Claim They’re Served Low-Quality Meals, Are Left Hungry
https://kffhealthnews.org/morning-breakout/ice-detainees-claim-theyre-served-low-quality-meals-are-left-hungry/
USA Today reports on food quality at a Louisiana ICE hub, where detainees say they are subject to a diet of processed foods that are often expired and never fully sate their hunger. A Guardian report highlights ICE detention conditions of perpetual twilight under fluorescent lights.
White House Warns Of Repercussions For Using Artificial Food Dyes
https://kffhealthnews.org/morning-breakout/white-house-warns-of-repercussions-for-using-artificial-food-dyes/
At a health industry conference on Tuesday, White House adviser Calley Means announced that regulations might be imposed on food companies that don't switch away from synthetics. Also: The soda industry pits MAGA against MAHA; experts weigh in on the seed oil scandal; and more.
Individualized Therapies on the RISE November 20, 2025 — 9:30AM–5:00PM
https://healthpolicy.duke.edu/events/individualized-therapies-rise?utm_medium=email&utm_source=govdelivery
Registration is now open to attend the FDA Rare Disease Innovation Hub’s November 20th Rare Disease Innovation, Science, and Exploration (RISE) Workshop on individualized therapies. Register here.
This public workshop will examine the emerging science and regulatory environment for individualized medicine programs, including nonclinical data recommendations, clinical assessments, regulatory submission structure, and additional information necessary to support the development, evaluation, and potential commercialization of these treatments.
The workshop will also provide opportunities for members of the rare disease community, including researchers, sponsors, patients, patient advocates, and regulators, to share their experiences with individualized medicine approaches. The goal of this workshop is to enhance understanding of regulatory considerations for individualized treatments and to inform future policy around individualized treatments.
Quality and Regulatory Predictability: Shaping USP Standards December 11, 2025
https://www.fda.gov/drugs/news-events-human-drugs/quality-and-regulatory-predictability-shaping-usp-standards-12112025?utm_medium=email&utm_source=govdelivery
By hosting this workshop, the Association for Accessible Medicines (AAM), FDA, and United States Pharmacopeia (USP) aim to increase stakeholder awareness of, and participation in, the USP standards development process, ultimately contributing to product quality and regulatory predictability throughout the drug development, approval, and product lifecycle.
Public quality standards are universally recognized as essential tools that support the design, manufacture, testing, and regulation of drug substances and products. USP standards play a critical role in helping ensure the quality and safety of medicines marketed in the United States and worldwide.
This discussion will show how USP public standards strengthen quality, streamline development, support regulatory compliance, and overall, increase regulatory predictability for drugs. Attendees will gain insights into the USP standards development process and learn how they can sponsor or participate—via public comment—in the development of future standards.
FDA Provides Update to Health Care Professionals About Risk of Inadvertent Intrathecal (Spinal) Administration of Tranexamic Acid Injection
https://www.fda.gov/drugs/drug-safety-and-availability/fda-provides-update-health-care-professionals-about-risk-inadvertent-intrathecal-spinal?utm_medium=email&utm_source=govdelivery
FDA Provides Update to Health Care Professionals About Risk of Inadvertent Intrathecal (Spinal) Administration of Tranexamic Acid Injection
FDA is requiring labeling changes to strengthen the warnings that tranexamic acid injection should be administered only intravenously (into the vein). Tranexamic acid injection products are not to be administered intrathecally (into the spine) or as an epidural injection. FDA is taking this action after having identified and evaluated medication error cases of inadvertent neuraxial (intrathecal or epidural) administration of tranexamic acid. In these cases, tranexamic acid was erroneously administered neuraxially instead of the intended local anesthetic (e.g., bupivacaine, lidocaine, mepivacaine, and ropivacaine), which resulted in serious patient outcomes, including prolonged hospitalization and death.
Medical practice-level and facility-level human factors (e.g., storing tranexamic acid injection close to local anesthetics and failing to verify the product before administration) contributed to the medication errors.
Tranexamic acid injection is indicated for short-term use (2 to 8 days) in patients with hemophilia to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. Health care professionals should only administer tranexamic acid injection by the intravenous route. Tranexamic acid injection is supplied in single-dose ampules and single-dose vials containing 1,000 mg tranexamic acid in 10 mL and is marketed both under the proprietary name, Cyklokapron, and as a generic drug. Tranexamic acid is also supplied in sodium chloride injection in single-dose bags containing 1,000 mg of tranexamic acid in 100 mL solution for intravenous use.
FDA is requiring the following changes to the prescribing information for tranexamic acid injection:
Add a Boxed Warning to communicate the risk of medication errors involving inadvertent neuraxial administration of tranexamic acid injection
Add a statement to indicate that tranexamic acid injection is contraindicated as a neuraxial injection
Update the Dosage and Administration section to clarify that tranexamic acid injection is only to be administered intravenously and to provide instructions for preparing and administering the diluted solution
Additionally, FDA is recommending that the container labels for tranexamic acid injection prominently display the product name and intravenous route of administration.
Chemistry, Manufacturing, and Controls Development and Readiness Pilot (CDRP) Program
https://www.fda.gov/drugs/pharmaceutical-quality-resources/chemistry-manufacturing-and-controls-development-and-readiness-pilot-cdrp-program?utm_medium=email&utm_source=govdelivery
FDA accepting requests to participate in CMC Development and Readiness Program
FDA is now accepting requests from drug sponsors to participate in the fourth year of the Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP) Program. This pilot program, described in the FDA Prescription Drug User Fee Act (PDUFA) VII Commitment Letter for fiscal years (FYs) 2023 through 2027, facilitates CMC readiness for selected Center for Biologics Evaluation and Research and Center for Drug Evaluation and Research-regulated products with accelerated clinical development timelines.
For drug and biological product sponsors participating in the pilot, FDA will provide product-specific CMC advice during product development, including two additional CMC-focused Type B meetings, as well as a limited number of additional CMC-focused discussions, based on CMC readiness and defined milestones. The increased communication between FDA review staff and drug sponsors is intended to ensure a mutual understanding of approaches to completing CMC activities to ensure CMC readiness for a marketing application.
https://www.federalregister.gov/documents/2025/08/28/2025-16513/chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-program-announcement?utm_medium=email&utm_source=govdelivery
martes, 21 de octubre de 2025
Editorial Resilience at the core: transforming primary health care in Latin America and the Caribbean The Lancet Regional Health – Americas + +... +++
The cost of inaction to strengthen the resilience of primary health care in Latin America and the Caribbean: a modelling study
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00258-3/fulltext?dgcid=hubspot_update_feature_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsenc=p2ANqtz--UvGjPwt0zfP78jEO3-psEaO-ifaD2q944x7UcTN2VelgNvj-J97dTQ4c33-RYKODwR99T8PUWW-pkJl1pUAkWkPyIGQ&_hsmi=385887207&utm_content=385656380&utm_source=hs_email
Editorial
Resilience at the core: transforming primary health care in Latin America and the Caribbean
The Lancet Regional Health – Americas
https://www.thelancet.com/journals/lanam/issue/vol50nonull/PIIS2667-193X(25)X0009-0
Gender, equity, and resilient primary health care in Latin America and the Caribbean: aligned and synergistic goals
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00270-4/fulltext?dgcid=hubspot_update_feature_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsenc=p2ANqtz-_D1O4F4jkXPEkaghic41NnWurX7iKSDn2j0od6SX4OOBaQV1B0Vu_rob5l33MpHOCpXA_2bWVURfEFbmzJRDkO8nnBkQ&_hsmi=385887207&utm_content=385656380&utm_source=hs_email
No time to wait: resilience as a cornerstone for primary health care across Latin America and the Caribbean, a World Bank-PAHO Lancet Regional Health Americas Commission
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00250-9/fulltext?dgcid=hubspot_update_feature_updatealerts_lanam&utm_campaign=update-lanam&utm_medium=email&_hsenc=p2ANqtz-8NMYe6BVmohQEOWcZaYmDw7_IoJQsFahzQ-YRn6pSWQZLmTLSBThb_XIvpTQLim5d2fMhBxq0v3Oqo08qMRNQedbT_JA&_hsmi=385887207&utm_content=385656380&utm_source=hs_email
The Lancet Regional Health Americas in conversation with
Ernesto Bascolo, Marcia Castro and Cristian Herrera on their Resilience in Primary Health Care Commission
October 10, 2025
•
The Lancet Group
https://thelancetamericas.buzzsprout.com/2517409/episodes/17962368-ernesto-bascolo-marcia-castro-and-cristian-herrera-on-their-resilience-in-primary-health-care-commission?utm_campaign=update-lanam&utm_medium=email&_hsenc=p2ANqtz-8nWzVlU1nVsryxUTAQu17AvQDADcohp8B9gzPmCfl5po-2AYyoweFyxFR5qh-v8dXgVwvYUr1uRua4eecRX5MhApmhqw&_hsmi=385887207&utm_content=385656380&utm_source=hs_email